Selected genes induced by both hypoxia and AdCA5
Unigene . | Gene name . | Symbol . | Hypoxia . | AdCA5 . |
---|---|---|---|---|
Oxidoreductases | ||||
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 11.5 | 16.4 |
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 3.1 | 5.0 |
Hs.443906 | Prolyl hydroxylase domain-containing protein 3 | EGLN3 | 4.6 | 5.0 |
Hs.318567 | N-myc downstream regulated gene 1 | NDRG1 | 2.2 | 3.7 |
Hs.88474 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | PTGS1 | 2.3 | 2.8 |
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 2.5 | 2.3 |
Hs.88474 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | PTGS1 | 1.6 | 2.2 |
Hs.130946 | Prolyl hydroxylase domain-containing protein 2 | EGLN1 | 2.4 | 2.1 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.7 | 1.9 |
Hs.10949 | ERO1-like | ERO1L | 1.7 | 1.8 |
Hs.179526 | Thioredoxin interacting protein | TXNIP | 2.6 | 1.7 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.6 | 1.7 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.8 | 1.7 |
Hs.83354 | Lysyl oxidase-like 2 | LOXL2 | 1.7 | 1.6 |
Collagens/modifying enzymes | ||||
Hs.102267 | Lysyl oxidase | LOX | 2.7 | 7.1 |
Hs.102267 | Lysyl oxidase | LOX | 2.4 | 6.7 |
Hs.104772 | Procollagen proline 4-hydroxylase, alpha 2 | P4HA2 | 2.0 | 4.6 |
Hs.232115 | Collagen, type 1, alpha 2 | COL1A2 | 4.5 | 4.1 |
Hs.41270 | Procollagen lysine hydroxylase 2 | PLOD2 | 2.2 | 3.5 |
Hs.433695 | Collagen, type V, alpha 1 | COL5A1 | 2.3 | 3.0 |
Hs.76768 | Procollagen proline 4-hydroxylase, alpha 1 | PRHA1 | 3.4 | 2.6 |
Hs.433695 | Collagen, type V, alpha 1 | COL5A1 | 2.4 | 2.6 |
Hs.41270 | Procollagen lysine hydroxylase 2 | PLOD2 | 1.8 | 2.6 |
Hs.413175 | Collagen, type XVIII, alpha 1 | COL18A1 | 1.8 | 2.0 |
Hs.149809 | Collagen, type IX, alpha 1 | COL9A1 | 1.7 | 1.8 |
Hs.437173 | Collagen, type IV, alpha 1 | COL4A1 | 1.6 | 1.7 |
Hs.407912 | Collagen, type IV, alpha 2 | COL4A2 | 1.6 | 1.7 |
Hs.75093 | Procollagen lysine hydroxylase | PLOD | 2.0 | 1.5 |
Hs.413175 | Collagen, type XVIII, alpha 1 | COL18A1 | 1.6 | 1.5 |
Growth factors/cytokines | ||||
Hs.9613 | Angiopoietin-like 4 | ANGPTL4 | 17.5 | 14.9 |
Hs.25590 | Stanniocalcin 1 | STC1 | 3.1 | 12.2 |
Hs.9613 | Inhibin, beta A (activin A, activin AB alpha) | INHBA | 10.2 | 11.6 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 6.7 | 8.8 |
Hs.279497 | Inhibin, beta E | INHBE | 2.2 | 4.8 |
Hs.155223 | Stanniocalcin 2 | STC2 | 2.3 | 4.3 |
Hs.511899 | Endothelin 1 | EDN1 | 1.9 | 4.0 |
Hs.2171 | Growth differentiation factor 10 | GDF10 | 1.5 | 3.3 |
Hs.450230 | Insulin-like growth factor binding protein 3 | IGFBP3 | 2.5 | 3.2 |
Hs.80420 | Chemokine (C-X3-C motif) ligand 1 | CX3CL1 | 2.1 | 2.9 |
Hs.79141 | Vascular endothelial growth factor C | VEGFC | 2.8 | 2.6 |
Hs.368996 | Relaxin 1 | RLN1 | 1.5 | 2.5 |
Hs.1976 | Platelet-derived growth factor B polypeptide | PDGFB | 1.9 | 2.5 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 2.5 | 2.4 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 1.9 | 2.2 |
Hs.252820 | Placental growth factor | PGF | 1.9 | 2.1 |
Hs.441047 | Adrenomedullin | ADM | 4.2 | 2.1 |
Hs.1976 | Platelet-derived growth factor B polypeptide | PDGFB | 2.3 | 1.7 |
Receptors | ||||
Hs.439141 | Gamma-aminobutyric acid (GABA) A receptor, pi | GABRP | 3.4 | 8.1 |
Hs.231853 | Chemokine orphan receptor 1 | CMKOR1 | 1.7 | 6.4 |
Hs.370422 | Very low density lipoprotein receptor | VLDLR | 2.0 | 5.9 |
Hs.198288 | Protein tyrosine phosphatase, receptor type, R | PTPRR | 6.0 | 5.6 |
Hs.166206 | Cubilin (intrinsic factor-cobalamin receptor) | CUBN | 2.0 | 4.5 |
Hs.421986 | Chemokine (C-X-C motif) receptor 4 | CXCR4 | 3.1 | 2.9 |
Hs.197029 | Adenosine A2a receptor | ADORA2A | 2.3 | 2.8 |
Hs.438864 | Natriuretic peptide receptor A/guanylate cyclase A | NPR1 | 1.8 | 2.7 |
Hs.438669 | Insulin receptor | INSR | 2.3 | 2.5 |
Hs.434375 | Protein tyrosine phosphatase, receptor type, B | PTPRB | 2.1 | 2.5 |
Hs.371974 | Activin A receptor, type IB | ACVR1B | 2.0 | 2.4 |
Hs.198288 | Protein tyrosine phosphatase, receptor type, R | PTPRR | 5.1 | 2.3 |
Hs.434375 | Protein tyrosine phosphatase, receptor type, B | PTPRB | 2.6 | 2.2 |
Hs.17109 | Integral membrane protein 2A | ITM2A | 1.8 | 1.8 |
Hs.127826 | Erythropoietin receptor | EPOR | 1.7 | 1.8 |
Hs.334131 | Cadherin 2, type 1, N-cadherin (neuronal) | CDH2 | 1.6 | 1.8 |
Hs.51233 | TNF receptor superfamily, member 10b | TNFRSF10B | 1.6 | 1.7 |
Hs.279899 | TNF receptor superfamily, member 14 | TNFRSF14 | 1.5 | 1.7 |
Hs.170129 | Opsin 3 (encephalopsin, panopsin) | OPN3 | 1.5 | 1.6 |
Hs.23581 | Leptin receptor | LEPR | 2.6 | 1.6 |
Hs.75216 | Protein tyrosine phosphatase, receptor type, F | PTPRF | 1.7 | 1.5 |
Hs.512235 | Inositol 1,4,5-triphosphate receptor, type 2 | ITPR2 | 1.8 | 1.5 |
Hs.83341 | AXL receptor tyrosine kinase | AXL | 1.5 | 1.5 |
Hs.23581 | Leptin receptor | LEPR | 1.6 | 1.5 |
Hs.211569 | G protein—coupled receptor kinase 5 | GRK5 | 1.5 | 1.5 |
Other signal transduction | ||||
Hs.106070 | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | CDKN1C | 3.6 | 17.2 |
Hs.512298 | Phospholipase C, gamma 2 | PLCG2 | 2.1 | 4.8 |
Hs.200598 | AMP-activated protein kinase family member 5 | ARK5 | 1.5 | 4.5 |
Hs.287460 | PDZ domain containing 3 | PDZK3 | 4.4 | 4.2 |
Hs.106070 | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | CDKN1C | 1.6 | 3.9 |
Hs.213840 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | ENPP1 | 2.6 | 3.5 |
Hs.458389 | SPRY domain-containing SOCS box protein SSB-1 | SSB1 | 1.6 | 3.0 |
Hs.298654 | Dual specificity phosphatase 6 | DUSP6 | 2.3 | 2.9 |
Hs.44038 | Pellino homolog 2 | PELI2 | 1.9 | 2.8 |
Hs.301664 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 2 | RPS6KA2 | 1.7 | 2.7 |
Hs.10862 | Adenylate kinase 3 | AK3 | 5.7 | 2.6 |
Hs.15099 | Rho-related BTB domain containing 1 | RHOBTB1 | 1.6 | 2.6 |
Hs.288196 | Calcium/calmodulin-dependent serine protein kinase | CASK | 1.5 | 2.6 |
Hs.173380 | CK2 interacting protein 1 | CKIP-1 | 1.5 | 2.3 |
Hs.82294 | Regulator of G-protein signaling 3 | RGS3 | 1.9 | 2.3 |
Hs.112378 | LIM and senescent cell antigen-like domains 1 | LIMS1 | 1.6 | 2.2 |
Hs.10862 | Adenylate kinase 3 | AK3 | 3.8 | 2.1 |
Hs.80905 | Ras association (RalGDS/AF-6) domain family 2 | RASSF2 | 1.5 | 1.8 |
Hs.299883 | FAD104 | FAD104 | 1.6 | 1.8 |
Hs.446403 | WAS protein family, member 2 | WASF2 | 1.6 | 1.8 |
Hs.110571 | Growth arrest and DNA-damage-inducible, beta | GADD45B | 2.3 | 1.7 |
Hs.13291 | Cyclin G2 | CCNG2 | 1.5 | 1.7 |
Hs.129836 | Cyclin-dependent kinase (CDC2-like) 11 | CDK11 | 1.5 | 1.7 |
Hs.367689 | Triple functional domain (PTPRF interacting) | TRIO | 1.5 | 1.7 |
Hs.301664 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 2 | RPS6KA2 | 1.7 | 1.6 |
Hs.9651 | Related RAS viral (r-ras) oncogene homolog | RRAS | 2.1 | 1.6 |
Hs.301242 | Myocytic induction/differentiation originator | MIDOR1 | 1.9 | 1.5 |
Hs.497972 | FK506 binding protein 9, 63 kDa | FKBP9 | 1.5 | 1.5 |
Transcription factors | ||||
Hs.460889 | V-maf oncogene homolog F | MAFF | 2.1 | 5.0 |
Hs.387667 | Peroxisome proliferative activated receptor, gamma | PPARG | 16.8 | 3.9 |
Hs.232068 | Transcription factor 8 | TCF8 | 1.7 | 3.3 |
Hs.321707 | Jumonji domain containing 1 | JMJD1 | 2.1 | 3.1 |
Hs.511938 | Zinc finger and BTB domain containing 1 | ZBTB1 | 1.7 | 2.9 |
Hs.420830 | Hypoxia-inducible factor 3, alpha subunit | HIF3A | 1.6 | 2.7 |
Hs.357901 | SRY (sex-determining region Y)-box 4 | SOX4 | 1.7 | 2.3 |
Hs.171825 | Basic helix-loop-helix domain containing, class B, 2 | BHLHB2 | 3.4 | 2.3 |
Hs.324051 | RelA-associated inhibitor | RAI | 2.8 | 2.1 |
Hs.321164 | Neuronal PAS domain protein 2 | NPAS2 | 1.6 | 2.1 |
Hs.436100 | Notch homolog 4 | NOTCH4 | 2.6 | 2.1 |
Hs.118630 | MAX interacting protein 1 | MXI1 | 3.0 | 2.0 |
Hs.415033 | Myocyte enhancer factor 2A | MEF2A | 1.8 | 2.0 |
Hs.406491 | Transducin-like enhancer of split 1 homolog | TLE1 | 1.5 | 1.9 |
Hs.75063 | HIV-1 enhancer binding protein 2 | HIVEP2 | 1.8 | 1.9 |
Hs.318517 | Transcription factor 7-like 1 | TCF7L1 | 1.8 | 1.9 |
Hs.448341 | Zinc finger protein 292 | ZNF292 | 1.9 | 1.8 |
Hs.55967 | Short stature homeobox 2 | SHOX2 | 1.7 | 1.8 |
Hs.357901 | SRY box 4 | SOX4 | 1.5 | 1.8 |
Hs.179526 | Thioredoxin interacting protein | TXNIP | 2.6 | 1.7 |
Hs.250666 | Hairy and enhancer of split 1 | HES1 | 2.2 | 1.7 |
Hs.30209 | Zinc fingers and homeoboxes 2 | ZHX2 | 2.3 | 1.6 |
Hs.155024 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | BCL6 | 1.7 | 1.6 |
Hs.511950 | Sirtuin (sir2 homolog) 3 | SIRT3 | 1.7 | 1.6 |
Hs.250666 | Hairy and enhancer of split 1 | HES1 | 2.0 | 1.6 |
Hs.153863 | MAD, mothers against decapentaplegic homolog 6 | MADH6 | 1.9 | 1.6 |
Hs.171825 | Basic helix-loop-helix domain containing, class B, 2 | BHLHB2 | 2.2 | 1.5 |
Hs.77810 | Nuclear factor of activated T cells 4 | NFATC4 | 1.9 | 1.5 |
Hs.59943 | cAMP responsive element binding protein 3-like 2 | CREB3L2 | 1.5 | 1.5 |
Unigene . | Gene name . | Symbol . | Hypoxia . | AdCA5 . |
---|---|---|---|---|
Oxidoreductases | ||||
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 11.5 | 16.4 |
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 3.1 | 5.0 |
Hs.443906 | Prolyl hydroxylase domain-containing protein 3 | EGLN3 | 4.6 | 5.0 |
Hs.318567 | N-myc downstream regulated gene 1 | NDRG1 | 2.2 | 3.7 |
Hs.88474 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | PTGS1 | 2.3 | 2.8 |
Hs.302085 | Prostaglandin I2 (prostacyclin) synthase | PTGIS | 2.5 | 2.3 |
Hs.88474 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | PTGS1 | 1.6 | 2.2 |
Hs.130946 | Prolyl hydroxylase domain-containing protein 2 | EGLN1 | 2.4 | 2.1 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.7 | 1.9 |
Hs.10949 | ERO1-like | ERO1L | 1.7 | 1.8 |
Hs.179526 | Thioredoxin interacting protein | TXNIP | 2.6 | 1.7 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.6 | 1.7 |
Hs.352733 | Peptidylglycine alpha-amidating monooxygenase | PAM | 1.8 | 1.7 |
Hs.83354 | Lysyl oxidase-like 2 | LOXL2 | 1.7 | 1.6 |
Collagens/modifying enzymes | ||||
Hs.102267 | Lysyl oxidase | LOX | 2.7 | 7.1 |
Hs.102267 | Lysyl oxidase | LOX | 2.4 | 6.7 |
Hs.104772 | Procollagen proline 4-hydroxylase, alpha 2 | P4HA2 | 2.0 | 4.6 |
Hs.232115 | Collagen, type 1, alpha 2 | COL1A2 | 4.5 | 4.1 |
Hs.41270 | Procollagen lysine hydroxylase 2 | PLOD2 | 2.2 | 3.5 |
Hs.433695 | Collagen, type V, alpha 1 | COL5A1 | 2.3 | 3.0 |
Hs.76768 | Procollagen proline 4-hydroxylase, alpha 1 | PRHA1 | 3.4 | 2.6 |
Hs.433695 | Collagen, type V, alpha 1 | COL5A1 | 2.4 | 2.6 |
Hs.41270 | Procollagen lysine hydroxylase 2 | PLOD2 | 1.8 | 2.6 |
Hs.413175 | Collagen, type XVIII, alpha 1 | COL18A1 | 1.8 | 2.0 |
Hs.149809 | Collagen, type IX, alpha 1 | COL9A1 | 1.7 | 1.8 |
Hs.437173 | Collagen, type IV, alpha 1 | COL4A1 | 1.6 | 1.7 |
Hs.407912 | Collagen, type IV, alpha 2 | COL4A2 | 1.6 | 1.7 |
Hs.75093 | Procollagen lysine hydroxylase | PLOD | 2.0 | 1.5 |
Hs.413175 | Collagen, type XVIII, alpha 1 | COL18A1 | 1.6 | 1.5 |
Growth factors/cytokines | ||||
Hs.9613 | Angiopoietin-like 4 | ANGPTL4 | 17.5 | 14.9 |
Hs.25590 | Stanniocalcin 1 | STC1 | 3.1 | 12.2 |
Hs.9613 | Inhibin, beta A (activin A, activin AB alpha) | INHBA | 10.2 | 11.6 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 6.7 | 8.8 |
Hs.279497 | Inhibin, beta E | INHBE | 2.2 | 4.8 |
Hs.155223 | Stanniocalcin 2 | STC2 | 2.3 | 4.3 |
Hs.511899 | Endothelin 1 | EDN1 | 1.9 | 4.0 |
Hs.2171 | Growth differentiation factor 10 | GDF10 | 1.5 | 3.3 |
Hs.450230 | Insulin-like growth factor binding protein 3 | IGFBP3 | 2.5 | 3.2 |
Hs.80420 | Chemokine (C-X3-C motif) ligand 1 | CX3CL1 | 2.1 | 2.9 |
Hs.79141 | Vascular endothelial growth factor C | VEGFC | 2.8 | 2.6 |
Hs.368996 | Relaxin 1 | RLN1 | 1.5 | 2.5 |
Hs.1976 | Platelet-derived growth factor B polypeptide | PDGFB | 1.9 | 2.5 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 2.5 | 2.4 |
Hs.73793 | Vascular endothelial growth factor | VEGF | 1.9 | 2.2 |
Hs.252820 | Placental growth factor | PGF | 1.9 | 2.1 |
Hs.441047 | Adrenomedullin | ADM | 4.2 | 2.1 |
Hs.1976 | Platelet-derived growth factor B polypeptide | PDGFB | 2.3 | 1.7 |
Receptors | ||||
Hs.439141 | Gamma-aminobutyric acid (GABA) A receptor, pi | GABRP | 3.4 | 8.1 |
Hs.231853 | Chemokine orphan receptor 1 | CMKOR1 | 1.7 | 6.4 |
Hs.370422 | Very low density lipoprotein receptor | VLDLR | 2.0 | 5.9 |
Hs.198288 | Protein tyrosine phosphatase, receptor type, R | PTPRR | 6.0 | 5.6 |
Hs.166206 | Cubilin (intrinsic factor-cobalamin receptor) | CUBN | 2.0 | 4.5 |
Hs.421986 | Chemokine (C-X-C motif) receptor 4 | CXCR4 | 3.1 | 2.9 |
Hs.197029 | Adenosine A2a receptor | ADORA2A | 2.3 | 2.8 |
Hs.438864 | Natriuretic peptide receptor A/guanylate cyclase A | NPR1 | 1.8 | 2.7 |
Hs.438669 | Insulin receptor | INSR | 2.3 | 2.5 |
Hs.434375 | Protein tyrosine phosphatase, receptor type, B | PTPRB | 2.1 | 2.5 |
Hs.371974 | Activin A receptor, type IB | ACVR1B | 2.0 | 2.4 |
Hs.198288 | Protein tyrosine phosphatase, receptor type, R | PTPRR | 5.1 | 2.3 |
Hs.434375 | Protein tyrosine phosphatase, receptor type, B | PTPRB | 2.6 | 2.2 |
Hs.17109 | Integral membrane protein 2A | ITM2A | 1.8 | 1.8 |
Hs.127826 | Erythropoietin receptor | EPOR | 1.7 | 1.8 |
Hs.334131 | Cadherin 2, type 1, N-cadherin (neuronal) | CDH2 | 1.6 | 1.8 |
Hs.51233 | TNF receptor superfamily, member 10b | TNFRSF10B | 1.6 | 1.7 |
Hs.279899 | TNF receptor superfamily, member 14 | TNFRSF14 | 1.5 | 1.7 |
Hs.170129 | Opsin 3 (encephalopsin, panopsin) | OPN3 | 1.5 | 1.6 |
Hs.23581 | Leptin receptor | LEPR | 2.6 | 1.6 |
Hs.75216 | Protein tyrosine phosphatase, receptor type, F | PTPRF | 1.7 | 1.5 |
Hs.512235 | Inositol 1,4,5-triphosphate receptor, type 2 | ITPR2 | 1.8 | 1.5 |
Hs.83341 | AXL receptor tyrosine kinase | AXL | 1.5 | 1.5 |
Hs.23581 | Leptin receptor | LEPR | 1.6 | 1.5 |
Hs.211569 | G protein—coupled receptor kinase 5 | GRK5 | 1.5 | 1.5 |
Other signal transduction | ||||
Hs.106070 | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | CDKN1C | 3.6 | 17.2 |
Hs.512298 | Phospholipase C, gamma 2 | PLCG2 | 2.1 | 4.8 |
Hs.200598 | AMP-activated protein kinase family member 5 | ARK5 | 1.5 | 4.5 |
Hs.287460 | PDZ domain containing 3 | PDZK3 | 4.4 | 4.2 |
Hs.106070 | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | CDKN1C | 1.6 | 3.9 |
Hs.213840 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | ENPP1 | 2.6 | 3.5 |
Hs.458389 | SPRY domain-containing SOCS box protein SSB-1 | SSB1 | 1.6 | 3.0 |
Hs.298654 | Dual specificity phosphatase 6 | DUSP6 | 2.3 | 2.9 |
Hs.44038 | Pellino homolog 2 | PELI2 | 1.9 | 2.8 |
Hs.301664 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 2 | RPS6KA2 | 1.7 | 2.7 |
Hs.10862 | Adenylate kinase 3 | AK3 | 5.7 | 2.6 |
Hs.15099 | Rho-related BTB domain containing 1 | RHOBTB1 | 1.6 | 2.6 |
Hs.288196 | Calcium/calmodulin-dependent serine protein kinase | CASK | 1.5 | 2.6 |
Hs.173380 | CK2 interacting protein 1 | CKIP-1 | 1.5 | 2.3 |
Hs.82294 | Regulator of G-protein signaling 3 | RGS3 | 1.9 | 2.3 |
Hs.112378 | LIM and senescent cell antigen-like domains 1 | LIMS1 | 1.6 | 2.2 |
Hs.10862 | Adenylate kinase 3 | AK3 | 3.8 | 2.1 |
Hs.80905 | Ras association (RalGDS/AF-6) domain family 2 | RASSF2 | 1.5 | 1.8 |
Hs.299883 | FAD104 | FAD104 | 1.6 | 1.8 |
Hs.446403 | WAS protein family, member 2 | WASF2 | 1.6 | 1.8 |
Hs.110571 | Growth arrest and DNA-damage-inducible, beta | GADD45B | 2.3 | 1.7 |
Hs.13291 | Cyclin G2 | CCNG2 | 1.5 | 1.7 |
Hs.129836 | Cyclin-dependent kinase (CDC2-like) 11 | CDK11 | 1.5 | 1.7 |
Hs.367689 | Triple functional domain (PTPRF interacting) | TRIO | 1.5 | 1.7 |
Hs.301664 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 2 | RPS6KA2 | 1.7 | 1.6 |
Hs.9651 | Related RAS viral (r-ras) oncogene homolog | RRAS | 2.1 | 1.6 |
Hs.301242 | Myocytic induction/differentiation originator | MIDOR1 | 1.9 | 1.5 |
Hs.497972 | FK506 binding protein 9, 63 kDa | FKBP9 | 1.5 | 1.5 |
Transcription factors | ||||
Hs.460889 | V-maf oncogene homolog F | MAFF | 2.1 | 5.0 |
Hs.387667 | Peroxisome proliferative activated receptor, gamma | PPARG | 16.8 | 3.9 |
Hs.232068 | Transcription factor 8 | TCF8 | 1.7 | 3.3 |
Hs.321707 | Jumonji domain containing 1 | JMJD1 | 2.1 | 3.1 |
Hs.511938 | Zinc finger and BTB domain containing 1 | ZBTB1 | 1.7 | 2.9 |
Hs.420830 | Hypoxia-inducible factor 3, alpha subunit | HIF3A | 1.6 | 2.7 |
Hs.357901 | SRY (sex-determining region Y)-box 4 | SOX4 | 1.7 | 2.3 |
Hs.171825 | Basic helix-loop-helix domain containing, class B, 2 | BHLHB2 | 3.4 | 2.3 |
Hs.324051 | RelA-associated inhibitor | RAI | 2.8 | 2.1 |
Hs.321164 | Neuronal PAS domain protein 2 | NPAS2 | 1.6 | 2.1 |
Hs.436100 | Notch homolog 4 | NOTCH4 | 2.6 | 2.1 |
Hs.118630 | MAX interacting protein 1 | MXI1 | 3.0 | 2.0 |
Hs.415033 | Myocyte enhancer factor 2A | MEF2A | 1.8 | 2.0 |
Hs.406491 | Transducin-like enhancer of split 1 homolog | TLE1 | 1.5 | 1.9 |
Hs.75063 | HIV-1 enhancer binding protein 2 | HIVEP2 | 1.8 | 1.9 |
Hs.318517 | Transcription factor 7-like 1 | TCF7L1 | 1.8 | 1.9 |
Hs.448341 | Zinc finger protein 292 | ZNF292 | 1.9 | 1.8 |
Hs.55967 | Short stature homeobox 2 | SHOX2 | 1.7 | 1.8 |
Hs.357901 | SRY box 4 | SOX4 | 1.5 | 1.8 |
Hs.179526 | Thioredoxin interacting protein | TXNIP | 2.6 | 1.7 |
Hs.250666 | Hairy and enhancer of split 1 | HES1 | 2.2 | 1.7 |
Hs.30209 | Zinc fingers and homeoboxes 2 | ZHX2 | 2.3 | 1.6 |
Hs.155024 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | BCL6 | 1.7 | 1.6 |
Hs.511950 | Sirtuin (sir2 homolog) 3 | SIRT3 | 1.7 | 1.6 |
Hs.250666 | Hairy and enhancer of split 1 | HES1 | 2.0 | 1.6 |
Hs.153863 | MAD, mothers against decapentaplegic homolog 6 | MADH6 | 1.9 | 1.6 |
Hs.171825 | Basic helix-loop-helix domain containing, class B, 2 | BHLHB2 | 2.2 | 1.5 |
Hs.77810 | Nuclear factor of activated T cells 4 | NFATC4 | 1.9 | 1.5 |
Hs.59943 | cAMP responsive element binding protein 3-like 2 | CREB3L2 | 1.5 | 1.5 |